Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Convertible Note Interest The Mann Group L L C	Convertible Note Principal and Interest The Mann Group L L C	Common Stock	Common Stock Convertible Note Interest The Mann Group L L C	Common Stock Convertible Note Principal and Interest The Mann Group L L C	Additional Paid-in Capital	Additional Paid-in Capital Convertible Note Interest The Mann Group L L C	Additional Paid-in Capital Convertible Note Principal and Interest The Mann Group L L C	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ (250,538)			$ 2,638			$ 2,964,293				$ (3,217,469)
Beginning Balance (in shares) at Dec. 31, 2022				263,793
Issuance of common stock associated with at-the-market offering	1,199			$ 3			1,196
Issuance of common stock associated with at-the-market offering (in shares)				269
Issuance costs associated with at-the- market offering	(24)						(24)
Net issuance of common stock associated with stock options and restricted stock units	52			$ 2			50
Net issuance of common stock associated with stock options and restricted stock units (in shares)				206
Issuance of common stock pursuant to conversion notes		$ 55						$ 55
Issuance of common stock pursuant to conversion notes (in shares)					11
Stock-based compensation expense	3,655						3,655
Net Income (Loss)	(9,795)										(9,795)
Ending Balance at Mar. 31, 2023	(255,396)			$ 2,643			2,969,225				(3,227,264)
Ending Balance (in shares) at Mar. 31, 2023				264,279
Beginning Balance at Dec. 31, 2022	(250,538)			$ 2,638			2,964,293				(3,217,469)
Beginning Balance (in shares) at Dec. 31, 2022				263,793
Net Income (Loss)	(15,060)
Ending Balance at Jun. 30, 2023	(260,487)			$ 2,682			2,968,917			$ 443	(3,232,529)
Ending Balance (in shares) at Jun. 30, 2023				268,235
Beginning Balance at Mar. 31, 2023	(255,396)			$ 2,643			2,969,225				(3,227,264)
Beginning Balance (in shares) at Mar. 31, 2023				264,279
Issuance of common stock associated with at-the-market offering	1,583			$ 4			1,579
Issuance of common stock associated with at-the-market offering (in shares)				362
Issuance costs associated with at-the- market offering	(17)						(17)
Issuance of common stock from market price stock purchase plan	152						152
Issuance of common stock under Market Price Stock Purchase Plan (in shares)				36
Net issuance of common stock associated with stock options and restricted stock units	(8,544)			$ 32			(8,576)
Net issuance of common stock associated with stock options and restricted stock units (in shares)				3,279
Issuance of common stock pursuant to conversion notes		54						54
Issuance of common stock pursuant to conversion notes (in shares)					13
Stock-based compensation expense	5,580						5,580
Issuance of common stock under the employee stock purchase plan	923			$ 3			920
Issuance of common stock under the employee stock purchase plan (in shares)				266
Cumulative gain on available-for-sale securities	443									443
Net Income (Loss)	(5,265)										(5,265)
Ending Balance at Jun. 30, 2023	(260,487)			$ 2,682			2,968,917			$ 443	(3,232,529)
Ending Balance (in shares) at Jun. 30, 2023				268,235
Beginning Balance at Dec. 31, 2023	(246,168)			$ 2,700			2,980,539				(3,229,407)
Beginning Balance (in shares) at Dec. 31, 2023				270,034
Issuance of common stock associated with at-the-market offering	1,361						1,361
Issuance of common stock associated with at-the-market offering (in shares)				416
Net issuance of common stock associated with stock options and restricted stock units	266			$ 3			263
Net issuance of common stock associated with stock options and restricted stock units (in shares)				337
Issuance of common stock pursuant to conversion notes		$ 56						$ 56
Issuance of common stock pursuant to conversion notes (in shares)					15
Stock-based compensation expense	3,885						3,885
Net Income (Loss)	10,630										10,630
Ending Balance at Mar. 31, 2024	(229,970)			$ 2,703			2,986,104				(3,218,777)
Ending Balance (in shares) at Mar. 31, 2024				270,802
Beginning Balance at Dec. 31, 2023	(246,168)			$ 2,700			2,980,539				(3,229,407)
Beginning Balance (in shares) at Dec. 31, 2023				270,034
Net Income (Loss)	8,616
Ending Balance at Jun. 30, 2024	(225,780)			$ 2,740			2,992,271				(3,220,791)
Ending Balance (in shares) at Jun. 30, 2024				274,467
Beginning Balance at Mar. 31, 2024	(229,970)			$ 2,703			2,986,104				(3,218,777)
Beginning Balance (in shares) at Mar. 31, 2024				270,802
Net issuance of common stock associated with stock options and restricted stock units	(4,933)			$ 19			(4,952)
Net issuance of common stock associated with stock options and restricted stock units (in shares)				1,855
Issuance of common stock pursuant to conversion notes			$ 3,750			$ 15			$ 3,735
Issuance of common stock pursuant to conversion notes (in shares)						1,500
Stock-based compensation expense	6,428						6,428
Issuance of common stock under the employee stock purchase plan	959			$ 3			956
Issuance of common stock under the employee stock purchase plan (in shares)				310
Net Income (Loss)	(2,014)										(2,014)
Ending Balance at Jun. 30, 2024	$ (225,780)			$ 2,740			$ 2,992,271				$ (3,220,791)
Ending Balance (in shares) at Jun. 30, 2024				274,467